Following the regional HIMSS event, Jefferies & Company is recommending Allscripts Healthcare Solutions MDRX and McKesson Corporation MCK.
“On the physician side Allscripts (Buy) appeared to be the primary vendor used by attendees,” Jefferies & Company writes.
“We consider McKesson (Buy) the winner [on the hospital vender side] because its clients are going to stick with the vendor even though they feel MCK will have to be pushed on upgrades.”
Allscripts currently trades for $18.78; McKesson trades for $62.45.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst RatingsAllscripts Healthcare SolutionsHealth CareHealth Care DistributorsHealth Care TechnologyJefferies & CompanyMcKesson Corporation
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in